# Holographic dark energy from generalized entropies and extended infrared cut-offs

Preprint · Ke Chen, Simone D'Onofrio, Sergei D. Odintsov, Tanmoy Paul

- Archive id: arxiv:2610.11616
- Published: 2026-10-08
- arXiv: https://arxiv.org/abs/2610.11616
- Source URL: https://arxiv.org/abs/2610.11616
- PDF: https://arxiv.org/pdf/2610.11616
- Provenance: arxiv

## Abstract

We study holographic dark energy models constructed from generalized entropy functionals and local infrared cut-offs. Three entropies (Barrow and the three and five-parameter generalized entropies) are each combined with the Granda-Oliveros (GO) cut-off and two extensions, one adding a $γH^{-2}$ term and one a $γ\\ddot{H}/H$ term, the latter raising the dark-energy evolution equation to second order. The nine resulting models are constrained against DESI DR2 BAO, Pantheon+ and a Planck compressed CMB likelihood through an MCMC analysis, and compared using the Akaike and Bayesian information criteria. The Hubble constant is stable across all models. The $H^{-2}$ term is unconstrained in every case, as it becomes relevant only in the far future, and never improves on the GO cut-off. The $\\ddot{H}/H$ term, instead, is tightly constrained for Barrow and $S\_5$, where it improves the fit substantially, but not for $S\_3$. The best fit is obtained for Barrow entropy with the $\\ddot{H}/H$ cut-off, yet the Barrow exponent remains compatible with zero in all cases. The data thus favour a higher-order infrared cut-off, while showing no significant evidence for a departure from the Bekenstein-Hawking area law. We also investigate the dark energy equation of state (EoS) of $S\_3$ and $S\_5$, discovering quintessence-like behavior and phantom crossing.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.